52North
Generated by Meeveem AI
"Diagnostic and digital technologies in development for emergency care"
About 52North
52North is a Cambridge medical technology company developing diagnostic tests and software for emergency care. Founded in 2018 by University of Cambridge postgraduates, it works with patients and clinicians on technology designed to support decisions outside hospital. Its Aster platform measures cell-based and soluble biomarkers from a single sample.
Neutrocheck pairs a finger-prick blood test with an app to help identify people at risk of neutropenic sepsis during cancer treatment and is undergoing UK clinical trials. ACORN is a digital platform for acute oncology triage, being piloted at UK hospitals. The company’s products remain in development and are not authorised for sale. Patients and healthcare professionals contribute to design and clinical testing.
From clinical trials to device design
The clinical team runs trials with patients and healthcare professionals and feeds that work into product development. Device R&D designs and manufactures the physical tests. A separate digital R&D team builds the software, while quality and regulatory colleagues oversee safety and compliance. Market access and commercial colleagues manage partnerships and routes to market, supported by operations.
Hours and leave
52North offers hybrid and part-time options. Its published annual leave allowance is 28 days plus bank holidays.
18
Team Members
2018
Founded
Diagnostics
Sector
Hybrid
Work Environment